Circuit Denies Access To Unapproved FDA Drugs

Law360, New York (August 7, 2007, 12:00 AM EDT) -- A divided appellate court on Tuesday denied that terminally-ill patients have a constitutional right to experimental drugs, ruling that government regulators must protect even dying patients from potentially unsafe drugs.

In an 8-2 decision, the U.S. Court of Appeals for the District of Columbia Circuit ruled that the due process clause of the Fifth Amendment does not cover a terminally-ill patient's right to drugs which the U.S. Food and Drug Administration has yet to approve. The clause provides that “[n]o person shall be...deprived of life, liberty,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.